Membrane-bound COMT inhibition by Nebicapone.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A1013, doi. 10.1096/fasebj.21.6.a1013-a
- By:
- Publication type:
- Article
Works matching DE "AROMATIC amino acid decarboxylase inhibitors"
Results: 7
1
2
Pharmacokinetic characteristics of agents applied in the treatment of Parkinson's disease.
- Published in:
- Journal of Neurology, 2006, v. 253, p. 53, doi. 10.1007/s00415-006-3010-x
- By:
- Publication type:
- Article
3
Improvement of the Rett Syndrome Phenotype in a Mecp2 Mouse Model Upon Treatment with Levodopa and a Dopa-Decarboxylase Inhibitor.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 12, p. 2846, doi. 10.1038/npp.2014.136
- By:
- Publication type:
- Article
4
6-[F]Fluoro- l-DOPA Uptake in the Rat Pancreas is Dependent on the Tracer Metabolism.
- Published in:
- Molecular Imaging & Biology, 2014, v. 16, n. 3, p. 403, doi. 10.1007/s11307-013-0701-4
- By:
- Publication type:
- Article
5
Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease.
- Published in:
- Wiener Klinische Wochenschrift, 2016, v. 128, n. 13/14, p. 528, doi. 10.1007/s00508-016-1026-5
- By:
- Publication type:
- Article
6
Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
- Published in:
- Journal of Neural Transmission, 2003, v. 110, n. 3, p. 229, doi. 10.1007/s00702-002-0778-4
- By:
- Publication type:
- Article
7
Electroanalytical Characterisation of Dopa Decarboxylase Inhibitors Carbidopa and Benserazide on Multiwalled Carbon Nanotube and Poly(Nile blue A)Modified Glassy Carbon Electrodes.
- Published in:
- International Journal of Electrochemistry, 2011, p. 1, doi. 10.4061/2011/185864
- By:
- Publication type:
- Article